Advertisement

Imaging Modalities

  • Antonella PetrilloEmail author
  • Roberta Fusco
  • Orlando Catalano
Part of the Updates in Surgery book series (UPDATESSURG)

Abstract

This chapter provides an overview of imaging modalities currently employed in assessing colorectal cancer (CRC) recurrence in the pelvis. Special emphasis is given to the role of magnetic resonance imaging (MRI) and its significance in planning an effective therapeutic strategy in the individual patient.

Keywords

Magnetic Resonance Imaging Positron Emission Tomography Local Recurrence Positive Predictive Value Negative Predictive Value 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References

  1. 1.
    Abulafi AM, Williams NS (1994) Local recurrence of colorectal cancer: the problem, mechanisms, management and adjuvant therapy. Br J Surg 81:7–19CrossRefPubMedGoogle Scholar
  2. 2.
    Titu LV, Nicholson AA, Hartley JE et al (2006) Routine follow-up by magnetic resonance imaging does not improve detection of resectable local recurrences from colorectal cancer. Ann Surg 243:348–352CrossRefPubMedPubMedCentralGoogle Scholar
  3. 3.
    Goldberg RM, Fleming TR, Tangen CM et al (1998) Surgery for recurrent colon cancer: strategies for identifying resectable recurrence and success rates after resection. Eastern Cooperative Oncology Group, the North Central Cancer Treatment Group, and the Southwest Oncology Group. Ann Intern Med 129:27–35CrossRefPubMedGoogle Scholar
  4. 4.
    Huguier M, Houry S, Barrier A (2001) Local recurrence of cancer of the rectum. Am J Surg 182:437–439CrossRefPubMedGoogle Scholar
  5. 5.
    Schmidt GP, Baur-Melnyk A, Haug A et al (2009) Whole-body MRI at 1.5 T and 3 T compared with FDG-PET-CT for the detection of tumour recurrence in patients with colorectal cancer. Eur Radiol 19:1366–1378CrossRefPubMedGoogle Scholar
  6. 6.
    Dresen RC, Kusters M, Daniels-Gooszen AW et al (2010) Absence of tumor invasion into pelvic structures in locally recurrent rectal cancer: prediction with preoperative MR imaging. Radiology 256:143–150CrossRefPubMedGoogle Scholar
  7. 7.
    Guillem JG, Díaz-González JA, Minsky BD et al (2008) cT3N0 rectal cancer: potential overtreatment with preoperative chemoradiotherapy is warranted. J Clin Oncol 26:368–373CrossRefPubMedGoogle Scholar
  8. 8.
    Desch CE, Benson AB, Somerfield MR et al (2005) Colorectal cancer surveillance: 2005 update of an American Society of Clinical Oncology practice guideline. J Clin Oncol 23:8512–8519CrossRefPubMedGoogle Scholar
  9. 9.
    ESMO Guidelines Task Force (2005) ESMO minimum clinical recommendations for diagnosis, adjuvant treatment and follow-up of colon cancer. Ann Oncol 16:16–17CrossRefGoogle Scholar
  10. 10.
    ESMO Guidelines Task Force (2005) ESMO minimum clinical recommendations for diagnosis, adjuvant treatment and follow-up of advanced colorectal cancer. Ann Oncol 16:18–19CrossRefGoogle Scholar
  11. 11.
    ESMO Guidelines Task Force (2005) ESMO minimum clinical recommendations for diagnosis, adjuvant treatment and follow-up of rectal cancer. Ann Oncol 16:20–21CrossRefGoogle Scholar
  12. 12.
    Selzner M, Hany TF, Wildbrett P et al (2004) Does the novel PET/CT imaging modality impact on the treatment of patients with metastatic colorectal cancer of the liver? Ann Surg 240:1027-1034CrossRefPubMedPubMedCentralGoogle Scholar
  13. 13.
    Stueckle CA, Haegele KF, Jendreck M et al (2005) Improvements in detection of rectal cancer recurrence by multiplanar reconstruction. Radiologe 45:930–935CrossRefGoogle Scholar
  14. 14.
    Blomqvist L, Holm T, Goranson H et al (1996) MR imaging, CT and CEA scintigraphy in diagnosis of local recurrence of rectal cancer. Acta Radiol 37:779–784CrossRefPubMedGoogle Scholar
  15. 15.
    Pema PJ, Bennett WF, Bova JG et al (1994) CT vs MRI in diagnosis of recurrent recto sigmoid carcinoma. J Comput Assist Tomogr 18:256–261CrossRefPubMedGoogle Scholar
  16. 16.
    Mäkelä JT, Laitinen SO, Kairaluoma MI (1995) Five-year follow-up after radical surgery for colorectal cancer. Results of a prospective randomized trial. Arch Surg 130:1062–1067CrossRefPubMedGoogle Scholar
  17. 17.
    Bleeker WA, Mulder NH, Hermans J et al (2001) Value and cost of follow-up after adjuvant treatment of patients with Dukes’ C colonic cancer. Br J Surg 88:101–106CrossRefPubMedGoogle Scholar
  18. 18.
    Primrose JN, Perera R, Gray A et al (2014) FACS Trial Investigators. Effect of 3 to 5 years of scheduled CEA and CT follow-up to detect recurrence of colorectal cancer: the FACS randomized clinical trial. JAMA 311:263–270CrossRefPubMedGoogle Scholar
  19. 19.
    Nakamoto Y, Sakamoto S, Okada T et al (2007) Clinical value of manual fusion of PET and CT images in patients with suspected recurrent colorectal cancer. AJR Am J Roentgenol 188:257–267CrossRefPubMedGoogle Scholar
  20. 20.
    Maas M, Rutten IJ, Nelemans PJ et al (2011) What is the most accurate whole-body imaging modality for assessment of local and distant recurrent disease in colorectal cancer? A metaanalysis: imaging for recurrent colorectal cancer. Eur J Nucl Med Mol Imaging 38:1560–1571CrossRefPubMedPubMedCentralGoogle Scholar
  21. 21.
    Gearhart SL, Frassica D, Rosen R et al (2005) Improved staging with pretreatment positron emission tomography/computed tomography in low rectal cancer. Ann Surg Oncol 13:397–404CrossRefGoogle Scholar
  22. 22.
    Moore HG, Akhurst T, Larson SM et al (2003) A case-controlled study of 18-fluorodeoxyglucose positron emission tomography in the detection of pelvic recurrence in previously irradiated rectal cancer patients. J Am Coll Surg 197:22–28CrossRefPubMedGoogle Scholar
  23. 23.
    Even-Sapir E, Parag Y, Lerman H et al (2004) Detection of recurrence in patients with rectal cancer: PET/CT after abdomino-perineal or anterior resection. Radiology 232:815–822CrossRefPubMedGoogle Scholar
  24. 24.
    Peng NJ, Hu C, King TM et al (2013) Detection of resectable recurrences in colorectal cancer patients with 2-18Ffluoro-2-deoxy-D-glucose-positron emission tomography/computed tomography. Cancer Biother Radiopharm 28:479–487CrossRefPubMedPubMedCentralGoogle Scholar
  25. 25.
    Von Schulthess GK, Steinert HC, Hany TF (2006) Integrated PET/CT: current applications and future directions. Radiology 238:405–22CrossRefGoogle Scholar
  26. 26.
    Schaefer O, Langer M (2007) Detection of recurrent rectal cancer with CT, MRI and PET/CT. Eur Radiol 17:2044–2054CrossRefPubMedGoogle Scholar
  27. 27.
    Van Cutsem E, Nordlinger B, Cervantes A et al (2010) Advanced colorectal cancer: ESMO clinical practice guidelines for treatment. Ann Oncol 21(Suppl 5):93–97CrossRefGoogle Scholar
  28. 28.
    Dicle O, Obuz F, Cakmakci H (1999) Differentiation of recurrent rectal cancer and scarring with dynamic MR imaging. Br J Radiol 72:1155–1159CrossRefPubMedGoogle Scholar
  29. 29.
    Tan PL, Chan CL, Moore NR (2005) Radiological appearances in the pelvis following rectal cancer surgery. ClinRadiol 60:846–855Google Scholar
  30. 30.
    Messiou C, Chalmers AG, Boyle K et al (2008) Pre-operative MR assessment of recurrent rectal cancer. Br J Radiol 81:468–473CrossRefPubMedGoogle Scholar
  31. 31.
    Dresen RC, Kusters M, Daniels-Gooszen AW et al (2010) Absence of tumor invasion into pelvic structures in locally recurrent rectal cancer: prediction with preoperative MR imaging. Radiology 256:143–150CrossRefPubMedGoogle Scholar
  32. 32.
    Fusco R, Sansone M, Petrillo M et al (2011) Dynamic contrast enhanced magnetic resonance imaging in rectal cancer, rectal cancer – a multidisciplinary approach to management. Santoro GA (Ed.), ISBN: 978-953-307-758-1, InTech, DOI: 10.5772/26269Google Scholar
  33. 33.
    Fusco R, Petrillo A, Petrillo M, Sansone M (2013) Use of Tracer Kinetic Models for Selection of Semi-Quantitative Features for DCE-MRI Data Classification. Appl Magn Reson 44:1311–1324CrossRefGoogle Scholar
  34. 34.
    Fusco R, Sansone M, Petrillo M et al (2014) Role of magnetic resonance imaging in locally advanced rectal cancer, colorectal cancer - surgery, diagnostics and treatment. Khan J (Ed.), ISBN: 978-953-51-1231-0, InTech, DOI: 10.5772/56831Google Scholar
  35. 35.
    Petrillo A, Fusco R, Granata V et al (2014) Dynamic contrast enhanced-MRI in locally advanced rectal cancer: Value of Time Intensity Curve Visual Inspection to assess neo-adjuvant therapy response. The Journal of Physiology and Health. Photon 110:255–267Google Scholar
  36. 36.
    Petrillo M, Fusco R, Catalano O et al (2014) Assessment of neo-adjuvant therapy response in locally advanced rectal cancer using MR volumetry based on dynamic contrast enhanced images and diffusion-weighted data sets: A preliminary report. The Journal of Physiology and Health. Photon 110:268–278Google Scholar
  37. 37.
    Lambregts DM, Cappendijk VC, Maas M et al (2011) Value of MRI and diffusion-weighted MRI for the diagnosis of locally recurrent rectal cancer. Eur Radiol 21:1250–1258CrossRefPubMedPubMedCentralGoogle Scholar
  38. 38.
    Kim DJ, Kim JH, Lim JS et al (2010) Restaging of rectal cancer with MR imaging after concurrent chemotherapy and radiation therapy. Radiographics 30:503–516CrossRefPubMedGoogle Scholar
  39. 39.
    Barbaro B, Vitale R, Leccisotti L et al (2010) Restaging locally advanced rectal cancer with MR imaging after chemoradiation therapy. Radiographics 30:699–716CrossRefPubMedGoogle Scholar
  40. 40.
    Arulampalam T, Costa D, Visvikis D et al (2001) The impact of FDG-PET on the management algorithm for recurrent colorectal cancer. Eur J Nucl Med 28:1758–1765CrossRefPubMedGoogle Scholar
  41. 41.
    Imbriaco M, Akhurst T, Hilton S et al (2000) Whole-body FDG-PET in patients with recurrent colorectal carcinoma. A comparative study with CT. Clin Positron Imaging 3:107–114CrossRefPubMedGoogle Scholar
  42. 42.
    Järv V, Blomqvist L, Holm T et al (2000) Added value of CEA scintigraphy in the detection of recurrence of rectal carcinoma. Acta Radiol 41:629–633CrossRefPubMedGoogle Scholar
  43. 43.
    Ogunbiyi OA, Flanagan FL, Dehdashti F et al (1997) Detection of recurrent and metastatic colorectal cancer: comparison of positron emission tomography and computed tomography. Ann Surg Oncol 4:613–620CrossRefPubMedGoogle Scholar
  44. 44.
    Keogan MT, Lowe VJ, Baker ME et al (1997) Local recurrence of rectal cancer: evaluation with F-18 fluorodeoxyglucose PET imaging. Abdom Imaging 22:332–337CrossRefPubMedGoogle Scholar
  45. 45.
    Schiepers C, Penninckx F, De Vadder N et al (1995) Contribution of PET in the diagnosis of recurrent colorectal cancer: comparison with conventional imaging. Eur J Surg Oncol 21:517–22CrossRefPubMedGoogle Scholar
  46. 46.
    Kyoto Y, Momose M, Kondo C et al (2010) Ability of 18F-FDG PET/CT to diagnose recurrent colorectal cancer in patients with elevated CEA concentration. Ann Nucl Med 24:395–401CrossRefPubMedGoogle Scholar

Copyright information

© Springer-Verlag Italia 2016

Authors and Affiliations

  • Antonella Petrillo
    • 1
    Email author
  • Roberta Fusco
  • Orlando Catalano
  1. 1.Radiology, Department of Diagnostic Imaging, Radiant and Metabolic TherapyIstituto Nazionale Tumori - IRCCS Fondazione G. PascaleNaplesItaly

Personalised recommendations